HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Mendelsohn Selected Research

J Mendelsohn Research Topics

Disease

18Neoplasms (Cancer)
01/2019 - 01/2000
6Colonic Neoplasms (Colon Cancer)
07/2001 - 05/2000
5Breast Neoplasms (Breast Cancer)
03/2001 - 01/2000
4Carcinoma (Carcinomatosis)
07/2001 - 11/2000
2Head and Neck Neoplasms (Head and Neck Cancer)
05/2001 - 03/2001
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2001
1Squamous Cell Carcinoma of Head and Neck
05/2001
1Retinoblastoma (Glioblastoma, Retinal)
04/2001
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2001
1Neoplasm Metastasis (Metastasis)
03/2001
1Ovarian Neoplasms (Ovarian Cancer)
11/2000
1Hemorrhage
02/2000
1Necrosis
02/2000
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2000
1Thrombosis (Thrombus)
02/2000
1Disease Progression
02/2000
1Adenocarcinoma
01/2000

Drug/Important Bio-Agent (IBA)

13ErbB Receptors (EGF Receptor)IBA
09/2001 - 02/2000
7Cetuximab (Erbitux)FDA Link
05/2001 - 02/2000
7Epidermal Growth Factor (EGF)IBA
04/2001 - 01/2000
6Monoclonal AntibodiesIBA
03/2001 - 02/2000
5Transforming Growth Factor alpha (TGF-alpha)IBA
09/2001 - 07/2000
4Paclitaxel (Taxol)FDA LinkGeneric
07/2001 - 01/2000
4Cisplatin (Platino)FDA LinkGeneric
07/2001 - 02/2000
3Antisense OligonucleotidesIBA
07/2001 - 09/2000
3Messenger RNA (mRNA)IBA
07/2001 - 12/2000
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2001 - 09/2000
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2001 - 01/2000
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2016
2AgarIBA
07/2001 - 11/2000
2Proteins (Proteins, Gene)FDA Link
03/2001 - 12/2000
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
03/2001 - 09/2000
2OligonucleotidesIBA
11/2000 - 09/2000
1MitogensIBA
09/2001
1Phosphotransferases (Kinase)IBA
09/2001
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2001
1Antineoplastic Agents (Antineoplastics)IBA
07/2001
1Biological ProductsIBA
07/2001
1Topotecan (Hycamtin)FDA LinkGeneric
07/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2001
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2001
1CyclinsIBA
04/2001
1Retinoblastoma ProteinIBA
04/2001
1Heterogeneous-Nuclear Ribonucleoprotein KIBA
03/2001
1Irinotecan (Camptosar)FDA LinkGeneric
03/2001
1GemcitabineFDA Link
03/2001
1Peptide Elongation Factor 1 (EF-1)IBA
02/2001
1Histones (Histone)IBA
02/2001
1Trastuzumab (Herceptin)FDA Link
12/2000
1AntibodiesIBA
12/2000
1Tyrosine Kinase InhibitorsIBA
12/2000
1histidine-rich proteinsIBA
12/2000
1CD34 Antigens (CD34 Antigen)IBA
12/2000
1p21-Activated KinasesIBA
12/2000
1Cyclic AMP-Dependent Protein Kinase Type IIBA
11/2000
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
11/2000
1Cytostatic AgentsIBA
09/2000
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2000
1Pharmaceutical PreparationsIBA
07/2000
1CaspasesIBA
06/2000
1JNK Mitogen-Activated Protein KinasesIBA
06/2000
1Cyclin-Dependent Kinases (cdk Proteins)IBA
05/2000
1EcdysoneIBA
05/2000
1Cytotoxins (Cytolysins)IBA
02/2000
1Growth Factor ReceptorsIBA
02/2000
1A-factor (Streptomyces)IBA
02/2000

Therapy/Procedure

7Therapeutics
08/2015 - 01/2000
5Radiotherapy
03/2001 - 01/2000
3Drug Therapy (Chemotherapy)
03/2001 - 01/2000
2Aftercare (After-Treatment)
07/2001 - 09/2000
1Precision Medicine
08/2015
1Withholding Treatment
11/2000
1Injections
02/2000